Financial Statements — UBS
Balance Sheet
(in billions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Cash & Equivalents | 259.05 | 278.96 | 295.76 | 207.91 | 177.10 |
| Total Assets | 1,669.99 | 1,560.98 | 1,678.78 | 1,113.19 | 1,086.52 |
| Total Liabilities | 1,580.29 | 1,476.76 | 1,591.15 | 1,056.01 | 1,027.47 |
| Retained Earnings | 79.73 | 76.18 | 78.18 | 46.60 | 40.14 |
| Total Stockholder Equity | 89.70 | 84.22 | 87.64 | 57.18 | 59.05 |
Income Statement
(in billions USD) (except per-share rows)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Pretax Income | 2.19 | 1.47 | 29.24 | 2.62 | 2.59 |
| Tax Provision | (0.21) | 0.29 | 0.36 | 0.50 | 0.58 |
| Net Income | 2.40 | 1.18 | 28.88 | 2.12 | 2.01 |
| Basic EPS | 0.75 | 0.35 | 9.37 | 0.64 | 0.57 |
| Diluted EPS | 0.72 | 0.34 | 8.99 | 0.61 | 0.55 |
Cash Flow Statement
(in billions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Operating Cash Flow | 20.89 | 11.86 | 17.67 | 18.15 | (2.14) |
| Investing Cash Flow | (14.15) | 2.55 | 104.87 | (4.63) | 0.30 |
| Financing Cash Flow | (12.77) | (61.92) | (25.06) | (3.83) | 10.80 |
